MARKET

SRTS

SRTS

Sensus Healthcare Inc
NASDAQ
5.35
+0.02
+0.38%
After Hours: 3.910 -1.44 -26.92% 19:47 08/07 EDT
OPEN
5.35
PREV CLOSE
5.33
HIGH
5.50
LOW
5.30
VOLUME
228.81K
TURNOVER
--
52 WEEK HIGH
9.33
52 WEEK LOW
4.010
MARKET CAP
87.98M
P/E (TTM)
48.81
1D
5D
1M
3M
1Y
5Y
1D
Sensus Healthcare Q2 revenue misses expectations
Reuters · 13h ago
*Sensus Healthcare 2Q Rev $7.3M >SRTS
Dow Jones · 14h ago
Sensus Healthcare reports Q2 EPS (6c), consensus 1c
TipRanks · 14h ago
BRIEF-Sensus Healthcare Q2 Net Income USD -1.037 Million
Reuters · 14h ago
*Sensus Healthcare 2Q Loss/Shr 6c >SRTS
Dow Jones · 14h ago
Press Release: Sensus Healthcare Reports Second -3-
Dow Jones · 14h ago
SENSUS HEALTHCARE INC - EXITS QUARTER WITH $22.2 MLN CASH, NO DEBT - SEC FILING
Reuters · 14h ago
Sensus Healthcare Q2 2025 Results: Revenues Down to $7.3 Million, Net Loss at $1.0 Million, EPS at $0.06 Loss
Reuters · 14h ago
More
About SRTS
Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.

Webull offers Sensus Healthcare Inc stock information, including NASDAQ: SRTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRTS stock methods without spending real money on the virtual paper trading platform.